(SMMU) |
| 0 (0%) 04-14 14:36 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 50.67 |
| Resistance 1: | 50.53 |
| Pivot price: | 50.43 |
| Support 1: | 50.31 |
| Support 2: | 41.86 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sun, 12 Apr 2026
Technical Reactions to SMMU Trends in Macro Strategies - Stock Traders Daily
Wed, 01 Apr 2026
Trading the Move, Not the Narrative: (SMMU) Edition - Stock Traders Daily
Tue, 10 Mar 2026
Price-Driven Insight from (SMMU) for Rule-Based Strategy - Stock Traders Daily
Tue, 30 Sep 2025
Editorial: Targeting pulmonary endothelium in acute lung injury and acute respiratory distress syndrome - Frontiers
Thu, 21 Aug 2025
HerTACs Enable Tumor-Selective Lysosomal Degradation of Membrane and Extracellular Proteins via HER2 Trafficking - Wiley Online Library
Thu, 16 Jan 2025
Janus Kinase 2/ Signal Transducer and Activator of Transcription 3 Cyclooxygenase 2 Signaling Pathway Mediates the Effect of Central Angiotensin II on the Elevation of Rostral Ventrolateral Medulla Prostaglandin - American Heart Association Journals
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
